POLY 50 |
| Bacterial drug resistance is emerging as one of the most significant challenges to human health. Antimicrobial peptides (AMPs), which are produced by many tissues and cell types of invertebrates, insects, and humans, as part of their innate immune system, have attracted considerable interest as alternative antibiotics. However, all peptide based molecules suffer from a number of critical limitations. As a result, interest in novel mimics of AMPs has increased greatly over the last few years. We will describe our efforts to establish a robust platform for AMP mimics and how this has translated into an innovative bio-tech company with immense potential for solving some of the biggest challenges in modern medicine. |
|
Entrepreneurship in Polymers for Energy and the Environment
8:00 AM-12:05 PM, Sunday, April 6, 2008 Hilton New Orleans Riverside -- Grand Salon 18, Oral
Division of Polymer Chemistry |